Showing all 3 results

  • Placeholder
    In Stock

    Mesalazine Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, pH-Targeted PR Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative 5-ASA molecule.

    Active IngredientStrengthPrimary Clinical Function
    Mesalazine (5-ASA) USP/Ph.Eur.400 mg (PR)Initiation / Titration Standard: Base therapeutic unit for mild presentations or pediatric titration in pediatric gastroenterology.
    Mesalazine (5-ASA) USP/Ph.Eur.800 mg / 1200 mg (PR)Global Gastroenterology Standard: High-efficacy adult maintenance doses designed to improve patient compliance by drastically reducing the daily pill burden.
    ExcipientsMethacrylic Acid Copolymer Type B & C (Eudragit L/S) / Hypromellose / Triethyl Citrate / Iron Oxide Colors / TalcEnteric & Prolonged-Release Polymers / Plasticizer / Glidant (Engineered specifically to form an impenetrable, acid-resistant shield that strictly delays drug release until reaching the high-pH environment of the lower gastrointestinal tract)
  • Placeholder
    In Stock

    Mirabegron Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrophilic Matrix ER Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute physical stability of the extended-release polymers.

    Active IngredientStrengthPrimary Clinical Function
    Mirabegron Ph.Eur./USP25 mg (ER)Initiation / Renal Standard: Base therapeutic unit for assessing patient tolerance and for use in patients with severe renal or hepatic impairment.
    Mirabegron Ph.Eur./USP50 mg (ER)Global Urology Standard: High-efficacy adult maintenance therapy for maximum suppression of urge urinary incontinence and detrusor overactivity.
    ExcipientsPolyethylene Oxide / Hypromellose (HPMC) / Butylated Hydroxytoluene (BHT) / Magnesium Stearate / Premium Opadry FilmSwellable ER Polymer / Hydrophilic Matrix Base / Antioxidant / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the active ingredient over 24 hours)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urology dispensing regimens).

  • Placeholder
    In Stock

    Morphine Sulphate Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Extended-Release Matrix Tablet, packed exclusively in highly secure, tamper-evident Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.

    Active IngredientStrengthPrimary Clinical Function
    Morphine Sulphate USP/Ph.Eur.15 mg (SR)Initiation / Titration Standard: Base therapeutic unit for opioid-naïve patients starting around-the-clock chronic pain management.
    Morphine Sulphate USP/Ph.Eur.30 mg / 60 mg (SR)Global Oncology Standard: High-dose adult maintenance therapy for severe, opioid-tolerant terminal cancer and intractable neuropathic pain.
    ExcipientsHypromellose (HPMC) / Cetostearyl Alcohol / Lactose Monohydrate / Magnesium Stearate / Premium Color-Coded FilmHydrophilic Polymer / Lipophilic Retardant / Diluent / Lubricant (Engineered specifically to form an impenetrable, slow-eroding gel matrix in the GI tract, strictly metering the release of the narcotic over 12 hours)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic oncology dispensing regimens; frequently color-coded by strength to prevent fatal dispensing errors).